Nanomix Inc. is developing a rapid, mobile, point-of-care assay for the SARS-CoV-2 virus with the assistance of the US government.
The Emeryville, CA-based company is developing the Nanomix COVID-19 assay for its portable eLab analyzer for hospitals, nursing homes, assisted living facilities, or urgent and emergency care centers. It yields...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?